PTGS2 and oral cavity squamous cell carcinoma: In the model of oral squamous cell carcinoma, Tołoczko-Iwaniuk demonstrated that celecoxib, a well-known inhibitor of COX-2, increased levels of POX/PRODH and, as a result, led to apoptosis [81].